NDC 68547-211-20 - Xacduro
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68547-211
- Requested NDC
- 68547-211-20
- Package NDCs from labels
- 68547-211-20
- Manufacturer
- La Jolla Pharmaceutical Company | Entasis Therapeutics Inc. (ETI)
- Effective date
- 2025-11-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Xacduro - La Jolla Pharmaceutical Company | Entasis Therapeutics Inc. (ETI) | La Jolla Pharmaceutical Company | Entasis Therapeutics Inc. (ETI) | 2025-11-26 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Meitheal Pharmaceuticals Inc. | 139b4b2e-46f7-44a8-9cc1-774afa463b80 | 2026-07-23 | Warnings, Adverse reactions | DKQ4T82YE6 |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Meitheal Pharmaceuticals Inc. | 006f9a3f-b4e3-4aa5-ac65-6cc3d3e2582d | 2026-07-22 | Warnings, Adverse reactions | DKQ4T82YE6 |
| ampicillin and sulbactam | AMPICILLIN AND SULBACTAM | Sagent Pharmaceuticals | a67ae347-487d-4751-a841-b321e81db26f | 2026-07-21 | Warnings, Adverse reactions | DKQ4T82YE6 |
| UNASYN | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Roerig | 155c7ec0-5862-404f-b1d0-f278f8a8bbda | 2026-07-10 | Warnings, Adverse reactions | DKQ4T82YE6 |
| UNASYN | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Roerig | 12eeb72a-403d-41be-bae4-4cb930862884 | 2026-07-09 | Warnings, Adverse reactions | DKQ4T82YE6 |
| Ampicillin and Sulbactam | AMPICILLIN AND SULBACTAM | WG Critical Care, LLC | 72a37674-8cb2-4b40-aac8-d345ffcf22f2 | 2026-06-23 | Warnings, Adverse reactions | DKQ4T82YE6 |
| Ampicillin and Sulbactam | AMPICILLIN AND SULBACTAM | WG Critical Care, LLC | 9a722de6-9dc0-4fb9-b63a-225385aa3314 | 2026-06-23 | Warnings, Adverse reactions | DKQ4T82YE6 |
| Ampicillin and Sulbactam | AMPICILLIN AND SULBACTAM | WG Critical Care, LLC | 77158167-0c1e-4f01-a5b0-a3df8ad121f5 | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | DKQ4T82YE6 |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Meitheal Pharmaceuticals Inc. | e6cf14a8-3ed9-4a7a-ba69-be0b794cbdc4 | 2026-06-10 | Warnings, Adverse reactions | DKQ4T82YE6 |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Medical Purchasing Solutions, LLC. | 4e81c215-2ab6-87c6-e063-6294a90ac28c | 2026-04-02 | Warnings, Adverse reactions | DKQ4T82YE6 |
| Ampicillin and Sulbactam | AMPICILLIN AND SULBACTAM | Hikma Pharmaceuticals USA Inc. | a65a70bf-4283-4bc0-b576-00c9ab29bd64 | 2026-03-25 | Warnings, Adverse reactions | DKQ4T82YE6 |
| Ampicillin and Sulbactam | AMPICILLIN AND SULBACTAM | Hikma Pharmaceuticals USA Inc. | d3026cc0-95d8-44cf-be47-b5ebb8fd4568 | 2026-03-25 | Warnings, Adverse reactions | DKQ4T82YE6 |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Hospira, Inc | dc374fa4-350b-425d-a7db-7099fdc64cf1 | 2026-01-21 | Warnings, Adverse reactions | DKQ4T82YE6 |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Eugia US LLC | 437a26f4-776b-4f74-99b2-09ad79831b0c | 2025-12-18 | Warnings, Adverse reactions | DKQ4T82YE6 |
| Ampicillin Sodium and Sulbactam Sodium | AMPICILLIN SODIUM, SULBACTAM SODIUM | ONESOURCE SPECIALTY PHARMA LIMITED | 573aca0c-111e-4ed3-9bcd-18136cae12cc | 2025-11-28 | Warnings, Adverse reactions | DKQ4T82YE6 |
| 2606ce2c-ad3a-4c58-be0d-9a696d366d64 | c0167aec-a89d-4e96-afe5-2ccf3e89fe72 | 2025-11-26 | Warnings, Adverse reactions | 2606ce2c-ad3a-4c58-be0d-9a696d366d64 c0167aec-a89d-4e96-afe5-2ccf3e89fe72 | ||
| ampicillin sodium and sulbactam sodium | AMPICILLIN SODIUM AND SULBACTAM SODIUM | ONESOURCE SPECIALTY PHARMA LIMITED | 44181723-ef09-301b-e063-6394a90a2cad | 2025-11-21 | Warnings, Adverse reactions | DKQ4T82YE6 |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Eugia US LLC | 16fdfdb9-9e26-48d0-8838-570d30c8e897 | 2025-11-04 | Warnings, Adverse reactions | DKQ4T82YE6 |
| Ampicillin Sodium and Sulbactam Sodium | AMPICILLIN SODIUM, SULBACTAM SODIUM | Armas Pharmaceuticals Inc. | 409f8a6d-f54f-415f-994c-ecd2b820caab | 2025-10-31 | Warnings, Adverse reactions | DKQ4T82YE6 |
| ampicillin sodium and sulbactam sodium | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Civica, Inc. | e98a36a1-b75b-42b9-ad1a-05004e9587b6 | 2025-09-08 | Warnings, Adverse reactions | DKQ4T82YE6 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.